| Literature DB >> 33977218 |
Jennifer C Goldsack1, Ariel V Dowling2, David Samuelson3, Bray Patrick-Lake3, Ieuan Clay3.
Abstract
To support the successful adoption of digital measures into internal decision making and evidence generation for medical product development, we present a unified lexicon to aid communication throughout this process, and highlight key concepts including the critical role of participant engagement in development of digital measures. We detail the steps of bringing a successful proof of concept to scale, focusing on key decisions in the development of a new digital measure: asking the right question, optimized approaches to evaluating new measures, and whether and how to pursue qualification or acceptance. Building on the V3 framework for establishing verification and analytical and clinical validation, we discuss strategic and practical considerations for collecting this evidence, illustrated with concrete examples of trailblazing digital measures in the field.Entities:
Keywords: Acceptance; Digital endpoints; Digital measures; Patient centricity; Qualification; V3
Year: 2021 PMID: 33977218 PMCID: PMC8077605 DOI: 10.1159/000514730
Source DB: PubMed Journal: Digit Biomark ISSN: 2504-110X